By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Nucleic acids provider Integrated DNA Technologies said today that it has received a Phase II Small Business Innovation Research grant to continue developing a gene silencing technology project it is developing with a start-up firm called SilaGene.

The new technology uses U1 adapters to down-regulate gene expression at the pre-mRNA stage, which could be used as a method of gene silencing in potential therapeutic technologies.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

CNBC reports that there are thousands of genetic tests available for consumers to chose between.

In Nature this week: genomic analysis of ducks, whole-genome doubling among tumor samples, and more.

Aug
07
Sponsored by
Qiagen

This webinar will present the results of an evaluation of a web-based variant interpretation software system for clinical next-generation sequencing.